Endothelial PPAR-γ Protects Against Vascular Thrombosis by Downregulating P-Selectin Expression

Author:

Jin Hong1,Gebska Milena A.1,Blokhin Ilya O.1,Wilson Katina M.1,Ketsawatsomkron Pimonrat1,Chauhan Anil K.1,Keen Henry L.1,Sigmund Curt D.1,Lentz Steven R.1

Affiliation:

1. From the Departments of Internal Medicine (H.J., M.A.G., I.O.B., K.M.W., A.K.C., C.D.S., S.R.L.) and Pharmacology (P.K., H.L.K., C.D.S.), Interdisciplinary Graduate Program in Molecular and Cellular Biology (I.O.B.), University of Iowa Carver College of Medicine, Iowa City.

Abstract

Objective— We tested the hypothesis that endothelial peroxisome proliferator–activated receptor-γ protects against vascular thrombosis using a transgenic mouse model expressing a peroxisome proliferator–activated receptor-γ mutant (E-V290M) selectively in endothelium. Approach and Results— The time to occlusive thrombosis of the carotid artery was significantly shortened in E-V290M mice compared with nontransgenic littermates after either chemical injury with ferric chloride (5.1±0.2 versus 10.1±3.3 minutes; P =0.01) or photochemical injury with rose bengal (48±9 versus 74±9 minutes; P =0.04). Gene set enrichment analysis demonstrated the upregulation of NF-κB target genes, including P-selectin, in aortic endothelial cells from E-V290M mice ( P <0.001). Plasma P-selectin and carotid artery P-selectin mRNA were elevated in E-V290M mice ( P <0.05). P-selectin–dependent leukocyte rolling on mesenteric venules was increased in E-V290M mice compared with nontransgenic mice (53±8 versus 25±7 per minute; P =0.02). The shortened time to arterial occlusion in E-V290M mice was reversed by administration of P-selectin–blocking antibodies or neutrophil-depleting antibodies ( P =0.04 and P =0.02, respectively) before photochemical injury. Conclusions— Endothelial peroxisome proliferator–activated receptor-γ protects against thrombosis through a mechanism that involves downregulation of P-selectin expression and diminished P-selectin–mediated leukocyte–endothelial interactions.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3